Please login to the form below

Not currently logged in
Email:
Password:

Drug prices

This page shows the latest Drug prices news and features for those working in and with pharma, biotech and healthcare.

Novartis rejects claims it misled Senate over Cohen links

Novartis rejects claims it misled Senate over Cohen links

Novartis rejects claims it misled Senate over Cohen links. Report says Novartis discussed drug-pricing with the President’s former ‘fixer’. ... on “a handful of occasions”, and included a request for ideas on how to lower drug prices.

Latest news

More from news
Approximately 7 fully matching, plus 157 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Quizzed about disagreements. over drug prices, Stevens played down the suggestion of an adversarial approach. ... While the drug is an undoubted breakthrough in the disease, NHS England says the company needs to lower its prices before it can allow

  • Health on instalment Health on instalment

    For example, the ophthalmic drug Luxturna, approved last year, costs $850, 000 per dose. ... In a company statement, even chief medical officer of pharmacy benefit manager Express Scripts Steve Miller, usually a fierce critic of high drug prices, offered

  • The rise of real-world evidence The rise of real-world evidence

    Notably, manufacturers and government and private payers are responding to concerns about drug prices by tying payments to outcomes. ... Spark Therapeutics has a similar arrangement for its gene therapy. These agreements make real-world efficacy a

  • US health reforms US health reforms

    In fact, it’s safe to say most C-suite drug executives would hardly shed a tear upon news of Obamacare’s swift demise. ... added. President Trump himself has frequently called for lower drug prices. “Once healthcare reform is done and Obamacare has

  • A healthcare landscape going through seismic change A healthcare landscape going through seismic change

    insulation from the looming challenges which now include Brexit and drug pricing in the UK. ... The company is still reeling from its record £84.2m fine last December from the UK government’s Competition and Markets Authority for allegedly charging

More from intelligence
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... A roadmap to strategic drug pricing.

  • Oncology drugs under AMNOG

    Oncology drugs under AMNOG. Part 1: Segmentation and comparator choice - lessons for cancer drug market access in Germany. ... How to prepare. Germany is one of the largest pharmaceutical markets in Europe and drug prices there are used as reference

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics